Oncology
Kristen Spencer, D.O.
Associate Professor, Department of Medicine at NYU Grossman School of Medicine; Director, Phase 1 Developmental Therapeutics Program, Perlmutter Cancer Center
Kristen Spencer, DO, is a medical oncologist specializing in gastrointestinal and hepatobiliary malignancies. She serves as Director of the Phase 1 Developmental Therapeutics Program at NYU Langone Perlmutter Cancer Center, focusing on early-phase clinical trials evaluating immunotherapies, targeted therapies, and novel agents for advanced solid tumors. Her primary clinical practice involves patients with pancreatic cancer, hepatobiliary tumors (including cholangiocarcinoma and gallbladder adeno
15+
Years in Practice
Credentials
Education & Training
- Rutgers Health/Robert Wood Johnson Medical School — Fellowship, Hematology and Medical Oncology, 2017
- Rutgers Health/New Jersey Medical School — Residency, Emergency Medicine, 2013 - 2017
- Rowan University School of Osteopathic Medicine — D.O., Class of 2011
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- NYU Langone Hospitals
- NYU Langone Hospital—Brooklyn
Languages
English[2]
Experience
15+ years in practice